OXOGESTONE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C20H30O2
Molecular Weight	302.451
Optical Activity	UNSPECIFIED
Defined Stereocenters	7 / 7
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4([H])[C@@]3([H])CC[C@]12C)[C@@H](C)O

InChI

InChIKey=CNOGNHFPIBORED-JIKCGYBYSA-N

InChI=1S/C20H30O2/c1-12(21)18-7-8-19-17-5-3-13-11-14(22)4-6-15(13)16(17)9-10-20(18,19)2/h11-12,15-19,21H,3-10H2,1-2H3/t12-,15+,16-,17-,18-,19+,20-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C20H30O2
Molecular Weight	302.451
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	7 / 7
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4679651

Oxogestone, a progestin that was developed by Organon Inc. This compound was studied as an intramuscular contraceptive but was never marketed.

Approval Year

PubMed

Title	Date	PubMed
Clinical experiences concerning the intramuscular contraceptive oxogestone.	1972 Mar	4679651

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:44:45 GMT 2023` Edited by `admin` on `Fri Dec 15 16:44:45 GMT 2023`
Record UNII	A98264FU0C
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

OXOGESTONE

Official Name

English

20.BETA.-HYDROXY-19-NORPREGN-4-EN-3-ONE

Common Name

English

oxogestone [INN]

Common Name

English

Code System Code Type Description

EPA CompTox

DTXSID70189952